25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MEM (Memphasys) Stock Analysis
Buy, Hold or Sell?

Let's analyze Memphasys together

I guess you are interested in Memphasys Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Memphasys’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Memphasys’s Price Targets

I'm going to help you getting a better view of Memphasys Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Memphasys Ltd

I send you an email if I find something interesting about Memphasys Ltd.

1. Quick Overview

1.1. Quick analysis of Memphasys (30 sec.)










1.2. What can you expect buying and holding a share of Memphasys? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.00
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-76.3%

For what price can you sell your share?

Current Price per Share
A$0.00
Expected price per share
A$0.005 - A$0.005
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Memphasys (5 min.)




Live pricePrice per Share (EOD)
A$0.00
Intrinsic Value Per Share
A$-0.02 - A$-0.01
Total Value Per Share
A$-0.02 - A$-0.01

2.2. Growth of Memphasys (5 min.)




Is Memphasys growing?

Current yearPrevious yearGrowGrow %
How rich?$4.5m$4.9m-$365k-8.0%

How much money is Memphasys making?

Current yearPrevious yearGrowGrow %
Making money-$2.9m-$2.2m-$693.8k-23.4%
Net Profit Margin-7,403.4%-22,136.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Memphasys (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#633 / 853

Most Revenue
#623 / 853

Most Profit
#340 / 853

Most Efficient
#788 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Memphasys?

Welcome investor! Memphasys's management wants to use your money to grow the business. In return you get a share of Memphasys.

First you should know what it really means to hold a share of Memphasys. And how you can make/lose money.

Speculation

The Price per Share of Memphasys is A$0.004. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Memphasys.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Memphasys, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Memphasys.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-32.1%0.00-32.1%0.00-28.6%0.00-26.1%0.00-20.1%0.00-17.1%
Usd Book Value Change Per Share0.00-12.7%0.00-12.7%0.00-2.2%0.00-7.7%0.00-0.3%0.005.8%
Usd Dividend Per Share0.000.0%0.000.0%0.007.1%0.005.4%0.0014.6%0.007.3%
Usd Total Gains Per Share0.00-12.7%0.00-12.7%0.004.9%0.00-2.2%0.0014.3%0.0013.1%
Usd Price Per Share0.00-0.00-0.01-0.01-0.02-0.01-
Price to Earnings Ratio-3.64--3.64--7.81--15.44--43.42--28.09-
Price-to-Total Gains Ratio-9.17--9.17-45.27-199.17-135.04-72.02-
Price to Book Ratio2.37-2.37-3.60-5.15-7.94-9.34-
Price-to-Total Gains Ratio-9.17--9.17-45.27-199.17-135.04-72.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.00267
Number of shares374531
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (374531 shares)-190.85213.85
Gains per Year (374531 shares)-763.40855.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-763-773876-20845
20-1527-15361751-411700
30-2290-22992627-612555
40-3054-30623503-813410
50-3817-38254378-1014265
60-4580-45885254-1225120
70-5344-53516130-1425975
80-6107-61147005-1626830
90-6871-68777881-1827685
100-7634-76408757-2038540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.016.01.05.6%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%8.010.00.044.4%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%4.00.06.040.0%4.00.014.022.2%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%11.07.00.061.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Memphasys Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%0.000-83%0.000-40%0.000-97%0.000-321%
Book Value Per Share--0.0030.0030%0.004-21%0.004-16%0.004-25%0.003+16%
Current Ratio--0.3080.3080%0.404-24%0.386-20%2.305-87%1.661-81%
Debt To Asset Ratio--0.4500.4500%0.497-9%0.468-4%0.390+15%0.501-10%
Debt To Equity Ratio--0.8180.8180%0.986-17%0.884-7%0.701+17%1.592-49%
Dividend Per Share----0%0.000-100%0.000-100%0.001-100%0.000-100%
Enterprise Value--10858667.31010858667.3100%19977670.000-46%32424443.103-67%62996842.662-83%38700323.431-72%
Eps---0.002-0.0020%-0.002-11%-0.002-19%-0.001-37%-0.001-47%
Ev To Ebitda Ratio---3.283-3.2830%-8.459+158%-19.857+505%-55.929+1604%-35.221+973%
Ev To Sales Ratio--180.978180.9780%1299.699-86%1309.297-86%1114.504-84%802.680-77%
Free Cash Flow Per Share---0.002-0.0020%-0.002-3%-0.002-8%-0.002-9%-0.001-33%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000-154%0.000+58%0.000-85%0.000-172%
Gross Profit Margin--1.0251.0250%1.044-2%1.040-1%1.134-10%1.074-5%
Intrinsic Value_10Y_max---0.012----------
Intrinsic Value_10Y_min---0.021----------
Intrinsic Value_1Y_max---0.001----------
Intrinsic Value_1Y_min---0.002----------
Intrinsic Value_3Y_max---0.004----------
Intrinsic Value_3Y_min---0.005----------
Intrinsic Value_5Y_max---0.006----------
Intrinsic Value_5Y_min---0.010----------
Market Cap7934400.000-104%16173257.31016173257.3100%26580240.000-39%38451085.770-58%67304931.462-76%42459649.731-62%
Net Profit Margin---74.034-74.0340%-221.366+199%-124.030+68%-75.824+2%-44.266-40%
Operating Margin---67.081-67.0810%-193.509+188%-105.432+57%-64.580-4%-37.229-45%
Operating Ratio--88.44388.4430%237.407-63%142.187-38%86.914+2%48.760+81%
Pb Ratio1.352-75%2.3652.3650%3.599-34%5.153-54%7.944-70%9.341-75%
Pe Ratio-2.081+43%-3.641-3.6410%-7.812+115%-15.441+324%-43.422+1093%-28.092+672%
Price Per Share0.004-75%0.0070.0070%0.013-48%0.019-63%0.034-79%0.021-67%
Price To Free Cash Flow Ratio-2.388+43%-4.180-4.1800%-8.232+97%-13.405+221%-22.853+447%-19.902+376%
Price To Total Gains Ratio-5.240+43%-9.169-9.1690%45.270-120%199.174-105%135.037-107%72.024-113%
Quick Ratio--0.2660.2660%0.366-27%0.230+15%2.059-87%1.521-83%
Return On Assets---0.357-0.3570%-0.232-35%-0.246-31%-0.188-47%-0.211-41%
Return On Equity---0.650-0.6500%-0.461-29%-0.461-29%-0.334-49%-0.660+2%
Total Gains Per Share---0.001-0.0010%0.000-358%0.000-82%0.001-189%0.001-197%
Usd Book Value--4564201.4634564201.4630%4929279.908-7%4865847.605-6%5370935.688-15%3436073.129+33%
Usd Book Value Change Per Share---0.001-0.0010%0.000-83%0.000-40%0.000-97%0.000-321%
Usd Book Value Per Share--0.0020.0020%0.002-21%0.002-16%0.003-25%0.002+16%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.001-100%0.000-100%
Usd Enterprise Value--7248160.4297248160.4290%13335094.725-46%21643315.771-67%42050392.477-83%25832465.890-72%
Usd Eps---0.001-0.0010%-0.001-11%-0.001-19%-0.001-37%-0.001-47%
Usd Free Cash Flow---2582979.360-2582979.3600%-2155157.918-17%-2160392.230-16%-2094149.886-19%-1519097.301-41%
Usd Free Cash Flow Per Share---0.001-0.0010%-0.001-3%-0.001-8%-0.001-9%-0.001-33%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000-154%0.000+58%0.000-85%0.000-172%
Usd Market Cap5296212.000-104%10795649.25410795649.2540%17742310.200-39%25666099.751-58%44926041.751-76%28341816.195-62%
Usd Price Per Share0.003-75%0.0050.0050%0.009-48%0.013-63%0.022-79%0.014-67%
Usd Profit---2965049.018-2965049.0180%-2271247.515-23%-2208669.168-26%-1675013.019-44%-1370196.074-54%
Usd Revenue--40050.00040050.0000%10260.143+290%22810.478+76%41919.267-4%30562.289+31%
Usd Total Gains Per Share---0.001-0.0010%0.000-358%0.000-82%0.001-189%0.001-197%
 EOD+3 -5MRQTTM+0 -0YOY+9 -313Y+12 -285Y+4 -3610Y+10 -30

3.3 Fundamental Score

Let's check the fundamental score of Memphasys Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.081
Price to Book Ratio (EOD)Between0-11.352
Net Profit Margin (MRQ)Greater than0-74.034
Operating Margin (MRQ)Greater than0-67.081
Quick Ratio (MRQ)Greater than10.266
Current Ratio (MRQ)Greater than10.308
Debt to Asset Ratio (MRQ)Less than10.450
Debt to Equity Ratio (MRQ)Less than10.818
Return on Equity (MRQ)Greater than0.15-0.650
Return on Assets (MRQ)Greater than0.05-0.357
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Memphasys Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.004
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Memphasys Ltd

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company primarily develops Felix, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid oxidative stress assay; and AI-Port. In addition, the company offers ambient temperature storage product for human sperm. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.

Fundamental data was last updated by Penke on 2025-09-15 08:46:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Memphasys earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Memphasys to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -7,403.4%Β means thatΒ $-74.03 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Memphasys Ltd:

  • The MRQ is -7,403.4%. The company is making a huge loss. -2
  • The TTM is -7,403.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7,403.4%TTM-7,403.4%0.0%
TTM-7,403.4%YOY-22,136.6%+14,733.2%
TTM-7,403.4%5Y-7,582.4%+179.0%
5Y-7,582.4%10Y-4,426.6%-3,155.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,403.4%-85.5%-7,317.9%
TTM-7,403.4%-168.0%-7,235.4%
YOY-22,136.6%-210.0%-21,926.6%
3Y-12,403.0%-289.9%-12,113.1%
5Y-7,582.4%-382.7%-7,199.7%
10Y-4,426.6%-520.3%-3,906.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Memphasys is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Memphasys to theΒ Biotechnology industry mean.
  • -35.7% Return on Assets means thatΒ Memphasys generatedΒ $-0.36 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Memphasys Ltd:

  • The MRQ is -35.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -35.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-35.7%TTM-35.7%0.0%
TTM-35.7%YOY-23.2%-12.5%
TTM-35.7%5Y-18.8%-17.0%
5Y-18.8%10Y-21.1%+2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-35.7%-11.9%-23.8%
TTM-35.7%-12.0%-23.7%
YOY-23.2%-11.3%-11.9%
3Y-24.6%-12.0%-12.6%
5Y-18.8%-11.7%-7.1%
10Y-21.1%-13.8%-7.3%
4.3.1.3. Return on Equity

Shows how efficient Memphasys is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Memphasys to theΒ Biotechnology industry mean.
  • -65.0% Return on Equity means Memphasys generated $-0.65Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Memphasys Ltd:

  • The MRQ is -65.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -65.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-65.0%TTM-65.0%0.0%
TTM-65.0%YOY-46.1%-18.9%
TTM-65.0%5Y-33.4%-31.5%
5Y-33.4%10Y-66.0%+32.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-65.0%-14.2%-50.8%
TTM-65.0%-15.1%-49.9%
YOY-46.1%-15.1%-31.0%
3Y-46.1%-16.9%-29.2%
5Y-33.4%-17.5%-15.9%
10Y-66.0%-19.7%-46.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Memphasys Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Memphasys is operatingΒ .

  • Measures how much profit Memphasys makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Memphasys to theΒ Biotechnology industry mean.
  • An Operating Margin of -6,708.1%Β means the company generated $-67.08 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Memphasys Ltd:

  • The MRQ is -6,708.1%. The company is operating very inefficient. -2
  • The TTM is -6,708.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-6,708.1%TTM-6,708.1%0.0%
TTM-6,708.1%YOY-19,350.9%+12,642.7%
TTM-6,708.1%5Y-6,458.0%-250.1%
5Y-6,458.0%10Y-3,722.9%-2,735.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6,708.1%-154.1%-6,554.0%
TTM-6,708.1%-270.5%-6,437.6%
YOY-19,350.9%-254.3%-19,096.6%
3Y-10,543.2%-276.4%-10,266.8%
5Y-6,458.0%-350.8%-6,107.2%
10Y-3,722.9%-532.3%-3,190.6%
4.3.2.2. Operating Ratio

Measures how efficient Memphasys is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 88.44 means that the operating costs are $88.44 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Memphasys Ltd:

  • The MRQ is 88.443. The company is inefficient in keeping operating costs low. -1
  • The TTM is 88.443. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ88.443TTM88.4430.000
TTM88.443YOY237.407-148.964
TTM88.4435Y86.914+1.530
5Y86.91410Y48.760+38.154
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ88.4431.891+86.552
TTM88.4432.917+85.526
YOY237.4073.080+234.327
3Y142.1873.835+138.352
5Y86.9144.924+81.990
10Y48.7606.864+41.896
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Memphasys Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Memphasys is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.31Β means the company has $0.31 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Memphasys Ltd:

  • The MRQ is 0.308. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.308. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.308TTM0.3080.000
TTM0.308YOY0.404-0.096
TTM0.3085Y2.305-1.997
5Y2.30510Y1.661+0.645
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3083.480-3.172
TTM0.3083.795-3.487
YOY0.4044.104-3.700
3Y0.3864.607-4.221
5Y2.3055.762-3.457
10Y1.6616.164-4.503
4.4.3.2. Quick Ratio

Measures if Memphasys is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Memphasys to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.27Β means the company can pay off $0.27 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Memphasys Ltd:

  • The MRQ is 0.266. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.266. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.266TTM0.2660.000
TTM0.266YOY0.366-0.100
TTM0.2665Y2.059-1.793
5Y2.05910Y1.521+0.538
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2662.952-2.686
TTM0.2663.302-3.036
YOY0.3663.927-3.561
3Y0.2304.393-4.163
5Y2.0595.875-3.816
10Y1.5216.549-5.028
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Memphasys Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of MemphasysΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Memphasys to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.45Β means that Memphasys assets areΒ financed with 45.0% credit (debt) and the remaining percentage (100% - 45.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Memphasys Ltd:

  • The MRQ is 0.450. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.450. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.450TTM0.4500.000
TTM0.450YOY0.497-0.047
TTM0.4505Y0.390+0.060
5Y0.39010Y0.501-0.111
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4500.340+0.110
TTM0.4500.355+0.095
YOY0.4970.335+0.162
3Y0.4680.341+0.127
5Y0.3900.349+0.041
10Y0.5010.379+0.122
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Memphasys is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Memphasys to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 81.8% means that company has $0.82 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Memphasys Ltd:

  • The MRQ is 0.818. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.818. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.818TTM0.8180.000
TTM0.818YOY0.986-0.168
TTM0.8185Y0.701+0.117
5Y0.70110Y1.592-0.892
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8180.393+0.425
TTM0.8180.436+0.382
YOY0.9860.436+0.550
3Y0.8840.461+0.423
5Y0.7010.459+0.242
10Y1.5920.514+1.078
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Memphasys generates.

  • Above 15 is considered overpriced butΒ always compareΒ Memphasys to theΒ Biotechnology industry mean.
  • A PE ratio of -3.64 means the investor is paying $-3.64Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Memphasys Ltd:

  • The EOD is -2.081. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.641. Based on the earnings, the company is expensive. -2
  • The TTM is -3.641. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.081MRQ-3.641+1.560
MRQ-3.641TTM-3.6410.000
TTM-3.641YOY-7.812+4.171
TTM-3.6415Y-43.422+39.781
5Y-43.42210Y-28.092-15.330
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.081-2.537+0.456
MRQ-3.641-2.362-1.279
TTM-3.641-2.678-0.963
YOY-7.812-3.833-3.979
3Y-15.441-3.900-11.541
5Y-43.422-6.480-36.942
10Y-28.092-7.170-20.922
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Memphasys Ltd:

  • The EOD is -2.388. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.180. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.180. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.388MRQ-4.180+1.791
MRQ-4.180TTM-4.1800.000
TTM-4.180YOY-8.232+4.053
TTM-4.1805Y-22.853+18.674
5Y-22.85310Y-19.902-2.951
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.388-3.385+0.997
MRQ-4.180-3.040-1.140
TTM-4.180-3.676-0.504
YOY-8.232-4.421-3.811
3Y-13.405-5.258-8.147
5Y-22.853-8.587-14.266
10Y-19.902-9.639-10.263
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Memphasys is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 2.37 means the investor is paying $2.37Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Memphasys Ltd:

  • The EOD is 1.352. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.365. Based on the equity, the company is underpriced. +1
  • The TTM is 2.365. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.352MRQ2.365-1.014
MRQ2.365TTM2.3650.000
TTM2.365YOY3.599-1.234
TTM2.3655Y7.944-5.578
5Y7.94410Y9.341-1.398
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.3522.199-0.847
MRQ2.3651.995+0.370
TTM2.3652.190+0.175
YOY3.5992.415+1.184
3Y5.1532.574+2.579
5Y7.9443.805+4.139
10Y9.3414.462+4.879
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Memphasys Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Accumulated Other Comprehensive Income  739151890-8147664140-153-12
Long-term Assets Other  -7,741-3,151-10,892-1,201-12,093-327-12,41922,50910,090



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets12,430
Total Liabilities5,592
Total Stockholder Equity6,838
 As reported
Total Liabilities 5,592
Total Stockholder Equity+ 6,838
Total Assets = 12,430

Assets

Total Assets12,430
Total Current Assets1,619
Long-term Assets10,812
Total Current Assets
Cash And Cash Equivalents 278
Net Receivables 1,119
Inventory 165
Other Current Assets 57
Total Current Assets  (as reported)1,619
Total Current Assets  (calculated)1,619
+/-0
Long-term Assets
Property Plant Equipment 708
Long Term Investments 14
Intangible Assets 10,090
Long-term Assets  (as reported)10,812
Long-term Assets  (calculated)10,812
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,254
Long-term Liabilities338
Total Stockholder Equity6,838
Total Current Liabilities
Short-term Debt 4,473
Short Long Term Debt 4,413
Accounts payable 394
Other Current Liabilities 316
Total Current Liabilities  (as reported)5,254
Total Current Liabilities  (calculated)9,596
+/- 4,342
Long-term Liabilities
Long term Debt Total 336
Long-term Liabilities  (as reported)338
Long-term Liabilities  (calculated)336
+/- 2
Total Stockholder Equity
Common Stock57,280
Retained Earnings -50,430
Other Stockholders Equity -12
Total Stockholder Equity (as reported)6,838
Total Stockholder Equity (calculated)6,838
+/-0
Other
Capital Stock57,280
Cash and Short Term Investments 278
Common Stock Shares Outstanding 2,310,465
Current Deferred Revenue71
Liabilities and Stockholders Equity 12,430
Net Debt 4,531
Net Invested Capital 11,251
Net Working Capital -3,635
Property Plant and Equipment Gross 885
Short Long Term Debt Total 4,809



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-30
> Total Assets 
4,463
5,056
5,757
17,717
10,571
8,952
13,632
7,102
6,844
7,194
7,302
4,217
6,836
11,299
14,581
14,121
14,668
12,430
12,43014,66814,12114,58111,2996,8364,2177,3027,1946,8447,10213,6328,95210,57117,7175,7575,0564,463
   > Total Current Assets 
0
1,548
1,229
3,570
1,316
781
2,088
882
981
824
4,304
861
2,154
3,558
3,689
2,029
2,249
1,619
1,6192,2492,0293,6893,5582,1548614,3048249818822,0887811,3163,5701,2291,5480
       Cash And Cash Equivalents 
209
696
33
1,201
29
173
181
84
175
19
2
202
874
2,011
2,046
312
681
278
2786813122,0462,01187420221917584181173291,20133696209
       Short-term Investments 
0
0
0
0
0
0
0
0
38
43
3,825
0
0
0
0
0
43
0
043000003,825433800000000
       Net Receivables 
167
445
864
1,899
826
213
1,381
234
19
73
53
593
1,103
1,293
1,360
-43
1,315
1,119
1,1191,315-431,3601,2931,1035935373192341,3812138261,899864445167
       Other Current Assets 
40
33
39
83
34
24
126
263
775
733
424
659
1,280
388
208
1,672
122
57
571221,6722083881,280659424733775263126243483393340
   > Long-term Assets 
0
3,508
4,527
14,147
9,255
8,170
11,544
6,221
5,863
6,370
2,998
3,356
4,683
7,741
10,892
12,093
12,419
10,812
10,81212,41912,09310,8927,7414,6833,3562,9986,3705,8636,22111,5448,1709,25514,1474,5273,5080
       Property Plant Equipment 
2,275
1,786
1,687
1,373
1,564
1,183
6,827
425
68
62
41
23
28
1,195
2,601
2,340
2,098
708
7082,0982,3402,6011,19528234162684256,8271,1831,5641,3731,6871,7862,275
       Goodwill 
0
0
0
0
0
0
0
1,545
339
339
339
0
0
0
0
0
0
0
00000003393393391,5450000000
       Long Term Investments 
0
0
0
0
0
0
0
4,125
3,825
3,825
0
0
0
0
0
74
26
14
142674000003,8253,8254,1250000000
       Intangible Assets 
0
0
1,986
12,325
7,391
6,687
3,885
1,671
1,971
2,483
2,956
3,333
4,655
6,546
8,291
9,679
10,295
10,090
10,09010,2959,6798,2916,5464,6553,3332,9562,4831,9711,6713,8856,6877,39112,3251,98600
       Long-term Assets Other 
0
867
55
0
0
0
531
-6,221
-5,863
-6,370
-2,998
-3,356
-4,683
-7,741
-10,892
-12,093
-12,419
10,090
10,090-12,419-12,093-10,892-7,741-4,683-3,356-2,998-6,370-5,863-6,221531000558670
> Total Liabilities 
2,663
3,954
6,155
4,874
3,576
4,389
6,642
8,095
6,098
5,717
7,704
866
765
1,543
5,974
6,475
7,283
5,592
5,5927,2836,4755,9741,5437658667,7045,7176,0988,0956,6424,3893,5764,8746,1553,9542,663
   > Total Current Liabilities 
1,616
2,715
4,533
2,126
3,132
4,302
3,668
1,787
3,260
5,648
6,661
823
733
587
857
4,539
5,567
5,254
5,2545,5674,5398575877338236,6615,6483,2601,7873,6684,3023,1322,1264,5332,7151,616
       Short-term Debt 
0
0
1,175
100
0
1,068
479
480
2,586
4,843
5,719
475
4
136
269
3,659
4,658
4,473
4,4734,6583,65926913644755,7194,8432,5864804791,06801001,17500
       Short Long Term Debt 
0
0
0
0
0
0
0
6,716
2,166
4,840
5,741
472
319
26
181
3,561
4,547
4,413
4,4134,5473,561181263194725,7414,8402,1666,7160000000
       Accounts payable 
910
1,137
1,858
1,015
1,616
1,684
1,849
627
245
754
335
130
225
219
159
132
115
394
3941151321592192251303357542456271,8491,6841,6161,0151,8581,137910
       Other Current Liabilities 
706
1,579
2,196
658
1,516
1,549
1,340
680
429
4,894
6,326
693
508
232
419
681
747
316
3167476814192325086936,3264,8944296801,3401,5491,5166582,1961,579706
   > Long-term Liabilities 
0
1,239
1,622
2,748
444
88
2,974
6,308
2,785
29
1,012
42
32
956
5,117
1,935
1,716
338
3381,7161,9355,11795632421,012292,7856,3082,974884442,7481,6221,2390
       Long term Debt Total 
0
0
0
0
0
0
0
0
2,785
43
1,021
7
3
931
4,857
1,825
1,715
336
3361,7151,8254,857931371,021432,78500000000
       Capital Lease Obligations Min Short Term Debt
0
0
-1,175
-100
0
-1,068
-479
-480
-2,586
-4,827
-5,705
-465
3
905
1,743
-1,735
-2,832
-4,077
-4,077-2,832-1,7351,7439053-465-5,705-4,827-2,586-480-479-1,0680-100-1,17500
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
26
22
0
0
0
0
0
0
0
00000002226000000000
> Total Stockholder Equity
1,800
1,101
-398
12,843
6,995
4,562
1,823
-993
747
1,478
-402
3,352
6,071
9,756
8,607
7,647
7,385
6,838
6,8387,3857,6478,6079,7566,0713,352-4021,478747-9931,8234,5626,99512,843-3981,1011,800
   Retained Earnings -50,430-46,173-42,771-41,167-39,681-38,804-37,759-37,358-35,358-33,053-30,407-26,565-20,923-16,241-9,678-12,967-10,4430
   Accumulated Other Comprehensive Income 
0
943
1,492
1,161
1,103
1,042
588
69
217
926
936
1,016
1,451
739
890
76
140
-12
-12140768907391,4511,016936926217695881,0421,1031,1611,4929430
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue60
Cost of Revenue-1,628
Gross Profit-1,568-1,568
 
Operating Income (+$)
Gross Profit-1,568
Operating Expense-3,678
Operating Income-5,239-5,247
 
Operating Expense (+$)
Research Development2,139
Selling General Administrative1,245
Selling And Marketing Expenses111
Operating Expense3,6783,495
 
Net Interest Income (+$)
Interest Income305
Interest Expense-417
Other Finance Cost-305
Net Interest Income-417
 
Pretax Income (+$)
Operating Income-5,239
Net Interest Income-417
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,442-6,035
EBIT - interestExpense = -4,442
-4,442
-4,025
Interest Expense417
Earnings Before Interest and Taxes (EBIT)-4,025-4,025
Earnings Before Interest and Taxes (EBITDA)-3,308
 
After tax Income (+$)
Income Before Tax-4,442
Tax Provision-0
Net Income From Continuing Ops-4,442-4,442
Net Income-4,442
Net Income Applicable To Common Shares-4,442
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,299
Total Other Income/Expenses Net797417
 

Technical Analysis of Memphasys
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Memphasys. The general trend of Memphasys is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Memphasys's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Memphasys Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Memphasys Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.005 < 0.005 < 0.005.

The bearish price targets are: 0.005 > 0.005 > 0.005.

Know someone who trades $MEM? Share this with them.πŸ‘‡

Memphasys Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Memphasys Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Memphasys Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Memphasys Ltd.

Memphasys Ltd Daily Moving Average Convergence/Divergence (MACD) ChartMemphasys Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Memphasys Ltd. The current adx is .

Memphasys Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Memphasys Ltd.

Memphasys Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Memphasys Ltd.

Memphasys Ltd Daily Relative Strength Index (RSI) ChartMemphasys Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Memphasys Ltd.

Memphasys Ltd Daily Stochastic Oscillator ChartMemphasys Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Memphasys Ltd.

Memphasys Ltd Daily Commodity Channel Index (CCI) ChartMemphasys Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Memphasys Ltd.

Memphasys Ltd Daily Chande Momentum Oscillator (CMO) ChartMemphasys Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Memphasys Ltd.

Memphasys Ltd Daily Williams %R ChartMemphasys Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Memphasys Ltd.

Memphasys Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Memphasys Ltd.

Memphasys Ltd Daily Average True Range (ATR) ChartMemphasys Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Memphasys Ltd.

Memphasys Ltd Daily On-Balance Volume (OBV) ChartMemphasys Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Memphasys Ltd.

Memphasys Ltd Daily Money Flow Index (MFI) ChartMemphasys Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Memphasys Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-08-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-15STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Memphasys Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Memphasys Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.004
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Memphasys with someone you think should read this too:
  • Are you bullish or bearish on Memphasys? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Memphasys? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Memphasys Ltd

I send you an email if I find something interesting about Memphasys Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Memphasys Ltd.

Receive notifications about Memphasys Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.